A change from gonadotropin releasing hormone antagonist to gonadotropin releasing hormone agonist therapy does not affect the oncological outcomes in hormone sensitive prostate cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-4190
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A change from gonadotropin releasing hormone antagonist to gonadotropin releasing hormone agonist therapy does not affect the oncological outcomes in hormone sensitive prostate cancer ; volume:28 ; number:1 ; day:18 ; month:7 ; year:2018 ; pages:1-7 ; date:12.2018
Basic and Clinical Andrology ; 28, Heft 1 (18.7.2018), 1-7, 12.2018
- Classification
-
Medizin, Gesundheit
- Creator
-
Asakawa, Jumpei
- Contributor
-
Iguchi, Taro
Tamada, Satoshi
Yasuda, Sayaka
Ninomiya, Noriko
Kato, Minoru
Yamasaki, Takeshi
Ohmachi, Tetusji
Nakatani, Tatsuya
SpringerLink (Online service)
- DOI
-
10.1186/s12610-018-0074-2
- URN
-
urn:nbn:de:101:1-2018081121584279347573
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:19 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Asakawa, Jumpei
- Iguchi, Taro
- Tamada, Satoshi
- Yasuda, Sayaka
- Ninomiya, Noriko
- Kato, Minoru
- Yamasaki, Takeshi
- Ohmachi, Tetusji
- Nakatani, Tatsuya
- SpringerLink (Online service)
Other Objects (12)
Expression von Gonadotropin-Releasing-Hormon und Gonadotropin-Releasing-Hormon-Rezeptor in Endometriose-Gewebe
Expression von Gonadotropin-Releasing-Hormon und Gonadotropin-Releasing-Hormon-Rezeptor in Endometriose-Gewebe
A randomized controlled trial of gonadotropin-releasing hormone agonist versus gonadotropin-releasing hormone antagonist in Iranian infertile couples: oocyte gene expression
Effekt eines Gonadotropin-Releasing-Hormon Agonisten auf die Prolaktinsekretion
Pulsatile Gonadotropin-Releasing-Hormon-Therapie des männlichen hypogonadotropen Hypogonadismus
Gonadotropin-Releasing Hormon- und Gonadotropin-Therapie beim Hypogonadismus des Mannes : ein Therapie-Vergleich
Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis
Die Degradation von GnRH (Gonadotropin-Releasing-Hormon) durch Rattenlebercytosol
AXL receptor tyrosine kinase modulates gonadotropin-releasing hormone receptor signaling
Comparison of recombinant and urinary follicle-stimulating hormones over 2000 gonadotropin-releasing hormone antagonist cycles: a retrospective study
A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients
Untersuchungen zum Nachweis von Gonadotropin-Releasing-Hormon im Urin beim Menschen
Expression von Gonadotropin-Releasing-Hormon und Gonadotropin-Releasing-Hormon-Rezeptor in Endometriose-Gewebe
Expression von Gonadotropin-Releasing-Hormon und Gonadotropin-Releasing-Hormon-Rezeptor in Endometriose-Gewebe
A randomized controlled trial of gonadotropin-releasing hormone agonist versus gonadotropin-releasing hormone antagonist in Iranian infertile couples: oocyte gene expression
Effekt eines Gonadotropin-Releasing-Hormon Agonisten auf die Prolaktinsekretion
Pulsatile Gonadotropin-Releasing-Hormon-Therapie des männlichen hypogonadotropen Hypogonadismus
Gonadotropin-Releasing Hormon- und Gonadotropin-Therapie beim Hypogonadismus des Mannes : ein Therapie-Vergleich
Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis
Die Degradation von GnRH (Gonadotropin-Releasing-Hormon) durch Rattenlebercytosol
AXL receptor tyrosine kinase modulates gonadotropin-releasing hormone receptor signaling
Comparison of recombinant and urinary follicle-stimulating hormones over 2000 gonadotropin-releasing hormone antagonist cycles: a retrospective study
A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients
Untersuchungen zum Nachweis von Gonadotropin-Releasing-Hormon im Urin beim Menschen
Expression von Gonadotropin-Releasing-Hormon und Gonadotropin-Releasing-Hormon-Rezeptor in Endometriose-Gewebe
Expression von Gonadotropin-Releasing-Hormon und Gonadotropin-Releasing-Hormon-Rezeptor in Endometriose-Gewebe
A randomized controlled trial of gonadotropin-releasing hormone agonist versus gonadotropin-releasing hormone antagonist in Iranian infertile couples: oocyte gene expression
Effekt eines Gonadotropin-Releasing-Hormon Agonisten auf die Prolaktinsekretion
Pulsatile Gonadotropin-Releasing-Hormon-Therapie des männlichen hypogonadotropen Hypogonadismus
Gonadotropin-Releasing Hormon- und Gonadotropin-Therapie beim Hypogonadismus des Mannes : ein Therapie-Vergleich
Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis
Die Degradation von GnRH (Gonadotropin-Releasing-Hormon) durch Rattenlebercytosol
AXL receptor tyrosine kinase modulates gonadotropin-releasing hormone receptor signaling
Comparison of recombinant and urinary follicle-stimulating hormones over 2000 gonadotropin-releasing hormone antagonist cycles: a retrospective study
A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients